OpenAI’s investment highlights the intensifying race in neurotechnology, where Neuralink (led by Elon Musk) currently leads ...
The leak points to a premium, fitness-focused square that blends classic G-Shock design with modern health sensors ...
YD Bio entered a memorandum of understanding to merge with EG BioMed in a combination intended to advance DNA methylation-driven AI platforms for cancer diagnostics and drug development. The ...
As President Trump approaches one year back in office, the policies his administration pursues — and how those policies are ...
YD Bio Limited ('YD Bio” or the 'Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback